|
|
|
|
 |
|
SENSEX
|
 |
-4.30
|
-0.02%
|
|
24326.65
|
|
|
|
NIFTY
|
 |
-114.00
|
-0.15%
|
|
77844.52
|
|
|
|
Nasdaq
|
 |
512.81
|
2.02%
|
|
25838.94
|
|
|
|
Nikkei 225
|
 |
228.20
|
0.38%
|
|
59513.12
|
|
|
|
FTSE 100
|
 |
219.60
|
2.15%
|
|
10438.70
|
|
|
 |
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Private |
|
BSE Code |
543245
|
|
ISIN Demat |
INE068V01023
|
|
Book Value (Rs) |
628.70
|
|
|
NSE Code |
GLAND
|
|
Dividend Yield % |
0.96
|
|
Market Cap (Rs) |
308292.22
|
|
|
TTM PE(x) |
26.37
|
|
TTM EPS(Rs) |
70.96
|
|
Face Value(Rs.) |
1
|
|
|
|
|
|
|
|
|
|
|
|
Incorporation Year
|
20-03 1978
|
|
Registered Office
|
Survey No. 143-148, 150 & 151, Near Gandimaisamma ‘x’ Roads,D. P. Pally, Dundigal, Dundigal-gandimaisamma Mandal,Medchal- Malkajgiri District, Hyderabad, Telangana-500043 .
|
|
ISINNO
|
INE068V01023
|
|
Phone
|
040 30510999
|
|
E-mail
|
gland@glandpharma.com / investor@glandpharma.com |
|
URL
|
www.glandpharma.com |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
Srinivas Sadu
|
|
Managing Director
|
|
|
Company Secretary
|
Sampath Kumar Pallerlamudi
|
|
Listing
|
BSE,NSE
|
|
|
|
|
|
|
|
|
|
|
|